Solution Manual for Medical Dosage Calculations 11th Edition
Emeritus, Giangrasso, Shrimpton 0133940713 9780133940718
Test Bank: https://testbankpack.com/p/test-bank-for-medical-dosage-calculations-11th-edition-
emeritus-giangrasso-shrimpton-0133940713-9780133940718/
Solution Manual: https://testbankpack.com/p/solution-manual-for-medical-dosage-calculations-
11th-edition-emeritus-giangrasso-shrimpton-0133940713-9780133940718/
Chapter
2 Safe and Accurate Drug
Administration
Chapter Overview
C hapter 2 is a general introduction to the drug administration
process. It introduces the student to the role of the person who
administers patient medication and the various forms and routes by which medications
are administered. The student will begin to develop a vocabulary of terms necessary to
understand pertinent information about drugs and their administration, which will aid
in understanding the responsibilities of administering drugs safely. Safety, documenta-
tion, and accuracy are stressed throughout the text. Recent Joint Commission recom-
mendations are included, and the “Six Rights” of medication administration are discussed
extensively. The student will learn how to interpret drug prescriptions, medication orders,
medication administration records (MAR), drug labels and package inserts, and military
time. The roles of the FDA and other organizations concerned with decreasing medication
errors are discussed.
Instructor’s Notes
● The PowerPoint slides are particularly useful in presenting the material in
this chapter. Slides of drug prescriptions, medication orders, medication
administration records, drug labels, and package inserts can be projected
as the instructor explains their various components.
● Demonstrate actual examples of various forms of drugs (inhalers, tablets,
capsules, patches, suppositories), if available.
M02_OLSE8131_11_IM_C02.indd 4 2/26/15 7:50 AM
● Students who have learned this material in other courses may review this
chapter quickly.
● Discuss the abbreviations to be avoided in medication orders and docu-
mentation (the “Do Not Use List”).
4
© 2016 by Pearson Education, Inc.
M02_OLSE8131_11_IM_C02.indd 4 2/26/15 7:50 AM
Answers to Chapter 2 Additional Exercises 5
● Emphasize the importance of the need to be vigilant regarding drugs that
“Look Alike-Sound Alike.”
● The Nurse Alert newsletter of the Institute of Safe Medication Practice is
a good reference for medication safety issues; see Appendix B.
● Interpreting a drug order is very important for the rest of the course and
should be stressed.
● If the Internet is accessible in the classroom, pharmaceutical company Web
sites can be used to view actual package inserts (prescribing information)
for drugs.
Key Terms
automated medication Institute for Safe prescriber
dispensing cart (ADC) Medication Practice prescription
A.M./P.M. (ISMP) prn
bar code intracardiac (IC) q.i.d.
b.i.d. intradermal (ID) registration
body surface area (BSA) intramuscular (IM) symbol (®)
buccal intrathecal route
capsule intravenous (IV) safe dose range
computerized local/systemic side effect
physician order lot number standing order
entry (CPOE) medication stat
controlled substance administration subcutaneous
delayed-release record (MAR) (subcut)
(DR) medication order sublingual (SL)
dosage strength metered dose inhaler suspension
dry powder inhaler (MDI) sustained release (SR)
(DPI) meters squared (m2) syrup
elixir military time tablet
enteral national drug code t.i.d.
enteric-coated (NDC) topical
epidural nebulizer trade name
extended release (XL) oral (PO) trademark (™)
Federal Drug package insert transdermal
Administration parenteral unit dose
(FDA) pharmacist United States
generic name Physician’s Desk Pharmacopoeia
inhalation Reference (PDR) (USP)
Answers to Chapter 2 Additional Exercises
1. montelukast 2. Zocor 3. 100 mL
4. 200 mg/5 mL 5. 80 mg/20 mg per mL
6. (a) Anusol supp 7. (a) Omnicef & Glucophage
(b) 6 a.m. (b) 4
(c) 4 (c) 25 mg/h, transdermal
(d) Bonivar, Humulin N, Humulin R (d) by mouth
(e) December 16 (e) 2
© 2016 by Pearson Education, Inc.
M02_OLSE8131_11_IM_C02.indd 5 2/26/15 7:50 AM
6 Chapter 2 Safe and Accurate Drug Administration
8. (a) milnacipran HCl, tablets 9.
Standard Time Military Time
(b) fibromyalgia
(c) 12.5 milligrams 7:30 a.m. 0730h
(d) No, Savella is not approved 5:43 p.m. 1743h
for use in pediatrics 12 midnight. 2400h
(e) 200 milligrams daily 8:20 p.m. 2020h
12:57 p.m. 1257h
10:30 p.m. 2230h
3:32 p.m. 1532h
4:15 a.m. 0415h
12:04 a.m. 0004h
9:12 a.m. 0912h
10. (a) Administer Norvasc (amlodipine) ten milligrams by mouth daily. Do
not administer if the systolic blood pressure is less than 100.
(b) Administer morphine sulfate five milligrams subcutaneously every
four hours as needed for moderate to severe pain.
(c) Administer Methergine (methylergonovine maleate) two-tenths
milligram intramuscularly immediately, then administer two-tenths
milligram by mouth every six hours for six doses.
(d) Administer Ceftin (cefuroxime axetil) one and five-tenths grams by
intravenous piggyback thirty minutes before surgery, then administer
seven hundred fifty milligrams by intravenous piggyback every eight
hours for twenty-four hours.
(e) Administer heparin five thousand units subcutaneously every twelve
hours.
11. (a) Route 12. (a) 60 mg
(b) Frequency (b) 60 mg
(c) Dose and frequency (c) 60 mg
(d) Frequency (d) 20 mg
(e) Dose and frequency
Chapter 2 Examination Questions
Study the drug labels shown in • Figure 2.1 and supply the following information:
© 2016 by Pearson Education, Inc.
M02_OLSE8131_11_IM_C02.indd 6 2/26/15 7:50 AM
Chapter 2 Examination Questions 7
(a)
(b)
(c)
• Figure 2.1
Drug Labels for Questions 1–5.
1. What is the generic name of Viagra?
2. How many capsules are in the Tikosyn container?
3. What is the strength of the Singulair tablets?
© 2016 by Pearson Education, Inc.
M02_OLSE8131_11_IM_C02.indd 7 2/26/15 7:50 AM
Another document from Scribd.com that is
random and unrelated content:
electronic works, and the medium on which they may be stored, may
contain “Defects,” such as, but not limited to, incomplete, inaccurate or
corrupt data, transcription errors, a copyright or other intellectual
property infringement, a defective or damaged disk or other medium, a
computer virus, or computer codes that damage or cannot be read by
your equipment.
1.F.2. LIMITED WARRANTY, DISCLAIMER OF DAMAGES - Except
for the “Right of Replacement or Refund” described in paragraph 1.F.3,
the Project Gutenberg Literary Archive Foundation, the owner of the
Project Gutenberg™ trademark, and any other party distributing a
Project Gutenberg™ electronic work under this agreement, disclaim all
liability to you for damages, costs and expenses, including legal fees.
YOU AGREE THAT YOU HAVE NO REMEDIES FOR
NEGLIGENCE, STRICT LIABILITY, BREACH OF WARRANTY OR
BREACH OF CONTRACT EXCEPT THOSE PROVIDED IN
PARAGRAPH 1.F.3. YOU AGREE THAT THE FOUNDATION, THE
TRADEMARK OWNER, AND ANY DISTRIBUTOR UNDER THIS
AGREEMENT WILL NOT BE LIABLE TO YOU FOR ACTUAL,
DIRECT, INDIRECT, CONSEQUENTIAL, PUNITIVE OR
INCIDENTAL DAMAGES EVEN IF YOU GIVE NOTICE OF THE
POSSIBILITY OF SUCH DAMAGE.
1.F.3. LIMITED RIGHT OF REPLACEMENT OR REFUND - If you
discover a defect in this electronic work within 90 days of receiving it,
you can receive a refund of the money (if any) you paid for it by sending
a written explanation to the person you received the work from. If you
received the work on a physical medium, you must return the medium
with your written explanation. The person or entity that provided you
with the defective work may elect to provide a replacement copy in lieu
of a refund. If you received the work electronically, the person or entity
providing it to you may choose to give you a second opportunity to
receive the work electronically in lieu of a refund. If the second copy is
also defective, you may demand a refund in writing without further
opportunities to fix the problem.
1.F.4. Except for the limited right of replacement or refund set forth in
paragraph 1.F.3, this work is provided to you ‘AS-IS’, WITH NO
OTHER WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED,
INCLUDING BUT NOT LIMITED TO WARRANTIES OF
MERCHANTABILITY OR FITNESS FOR ANY PURPOSE.
1.F.5. Some states do not allow disclaimers of certain implied warranties
or the exclusion or limitation of certain types of damages. If any
disclaimer or limitation set forth in this agreement violates the law of the
state applicable to this agreement, the agreement shall be interpreted to
make the maximum disclaimer or limitation permitted by the applicable
state law. The invalidity or unenforceability of any provision of this
agreement shall not void the remaining provisions.
1.F.6. INDEMNITY - You agree to indemnify and hold the Foundation,
the trademark owner, any agent or employee of the Foundation, anyone
providing copies of Project Gutenberg™ electronic works in accordance
with this agreement, and any volunteers associated with the production,
promotion and distribution of Project Gutenberg™ electronic works,
harmless from all liability, costs and expenses, including legal fees, that
arise directly or indirectly from any of the following which you do or
cause to occur: (a) distribution of this or any Project Gutenberg™ work,
(b) alteration, modification, or additions or deletions to any Project
Gutenberg™ work, and (c) any Defect you cause.
Section 2. Information about the Mission of Project
Gutenberg™
Project Gutenberg™ is synonymous with the free distribution of
electronic works in formats readable by the widest variety of computers
including obsolete, old, middle-aged and new computers. It exists
because of the efforts of hundreds of volunteers and donations from
people in all walks of life.
Volunteers and financial support to provide volunteers with the
assistance they need are critical to reaching Project Gutenberg™’s goals
and ensuring that the Project Gutenberg™ collection will remain freely
available for generations to come. In 2001, the Project Gutenberg
Literary Archive Foundation was created to provide a secure and
permanent future for Project Gutenberg™ and future generations. To
learn more about the Project Gutenberg Literary Archive Foundation and
how your efforts and donations can help, see Sections 3 and 4 and the
Foundation information page at www.gutenberg.org.
Section 3. Information about the Project Gutenberg
Literary Archive Foundation
The Project Gutenberg Literary Archive Foundation is a non-profit
501(c)(3) educational corporation organized under the laws of the state
of Mississippi and granted tax exempt status by the Internal Revenue
Service. The Foundation’s EIN or federal tax identification number is
64-6221541. Contributions to the Project Gutenberg Literary Archive
Foundation are tax deductible to the full extent permitted by U.S. federal
laws and your state’s laws.
The Foundation’s business office is located at 809 North 1500 West, Salt
Lake City, UT 84116, (801) 596-1887. Email contact links and up to date
contact information can be found at the Foundation’s website and official
page at www.gutenberg.org/contact
Section 4. Information about Donations to the Project
Gutenberg Literary Archive Foundation
Project Gutenberg™ depends upon and cannot survive without
widespread public support and donations to carry out its mission of
increasing the number of public domain and licensed works that can be
freely distributed in machine-readable form accessible by the widest
array of equipment including outdated equipment. Many small donations
($1 to $5,000) are particularly important to maintaining tax exempt
status with the IRS.
The Foundation is committed to complying with the laws regulating
charities and charitable donations in all 50 states of the United States.
Compliance requirements are not uniform and it takes a considerable
effort, much paperwork and many fees to meet and keep up with these
requirements. We do not solicit donations in locations where we have not
received written confirmation of compliance. To SEND DONATIONS or
determine the status of compliance for any particular state visit
www.gutenberg.org/donate.
While we cannot and do not solicit contributions from states where we
have not met the solicitation requirements, we know of no prohibition
against accepting unsolicited donations from donors in such states who
approach us with offers to donate.
International donations are gratefully accepted, but we cannot make any
statements concerning tax treatment of donations received from outside
the United States. U.S. laws alone swamp our small staff.
Please check the Project Gutenberg web pages for current donation
methods and addresses. Donations are accepted in a number of other
ways including checks, online payments and credit card donations. To
donate, please visit: www.gutenberg.org/donate.
Section 5. General Information About Project
Gutenberg™ electronic works
Professor Michael S. Hart was the originator of the Project Gutenberg™
concept of a library of electronic works that could be freely shared with
anyone. For forty years, he produced and distributed Project
Gutenberg™ eBooks with only a loose network of volunteer support.
Project Gutenberg™ eBooks are often created from several printed
editions, all of which are confirmed as not protected by copyright in the
U.S. unless a copyright notice is included. Thus, we do not necessarily
keep eBooks in compliance with any particular paper edition.
Most people start at our website which has the main PG search facility:
www.gutenberg.org.
This website includes information about Project Gutenberg™, including
how to make donations to the Project Gutenberg Literary Archive
Foundation, how to help produce our new eBooks, and how to subscribe
to our email newsletter to hear about new eBooks.
